Publications by authors named "Gillian Bethune"

Claim this Profile
E
Extensive Intraductal Component (EIC) as the Most Predictive Factor for Residual Disease Post-Breast-Conserving Surgery With Close DCIS Margins: A Single Institutional Experience.
Ibrahim Elsharawi, Gillian Bethune

Int J Breast Cancer· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of carcinoma ecotypes in the tumor microenvironment predicts response to neoadjuvant therapy in early-stage breast cancer.
Karama Asleh, Gillian Bethune, Paola Marcato

Sci Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
THSD4 is a novel mediator of T cell exclusion and anti-PD-1 resistance in hormone receptor-positive breast cancer.
Olivia L Walker, Marie-Claire D Wasson, Vishnupriyan Kumar, Sarah Nersesian, Jaganathan Venkatesh, Gillian Bethune

Biomark Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is Oncotype DX testing informative for breast cancers with low ER expression? A retrospective review from a biomarker testing referral center.
John Loggie, Penelope J Barnes, Michael D Carter, Daniel Rayson, Gillian C Bethune

Breast· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALDH1A3 promotes invasion and metastasis in triple-negative breast cancer by regulating the plasminogen activation pathway.
Alamelu G Bharadwaj, Meghan E McLean, Margaret L Dahn, Hannah F Cahill, Marie-Claire D Wasson, Gillian Bethune

Mol Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using Deep Learning to Predict Final HER2 Status in Invasive Breast Cancers That are Equivocal (2+) by Immunohistochemistry.
Sean A Rasmussen, Valerie J Taylor, Alexi P Surette, Penny J Barnes, Gillian C Bethune

Appl Immunohistochem Mol Morphol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2 testing in metastatic breast cancer - Is reflex ISH testing necessary on HER2 IHC-equivocal (2+) cases?
Christopher R Liwski, Mathieu C Castonguay, Penny J Barnes, Daniel Rayson, Gillian C Bethune

Ann Diagn Pathol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of HER2 using the 2018 ASCO/CAP guideline update for invasive breast cancer: a critical look at cases classified as HER2 2+ by immunohistochemistry.
Valerie J Taylor, Penny J Barnes, Sean C Godwin, Gillian C Bethune

Virchows Arch· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor levels of the mediators of ErbB2-driven anoikis resistance correlate with breast cancer relapse in patients receiving trastuzumab-based therapies.
Alexi Surette, Byong Hoon Yoo, Tallal Younis, Kara Matheson, Tarek Rameh, Gillian Bethune

Breast Cancer Res Treat· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cystic neutrophilic granulomatous mastitis - a review of 12 consecutive cases.
Magdalene H Maung, Gillian C Bethune, Glenn Patriquin, Penny J Barnes

Histopathology· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolated Tumor Cells in Sentinel Lymph Nodes of Primary Invasive Breast Carcinoma: A Cohort Analysis.
Gillian C Bethune, Manolhas A Karkada, Ryan DeCoste, Penny J Barnes, Daniel Rayson

Clin Breast Cancer· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ErbB2-driven downregulation of the transcription factor Irf6 in breast epithelial cells is required for their 3D growth.
Iman Aftab Khan, Byong Hoon Yoo, Michael McPhee, Olivier Masson, Alexi Surette, Gillian Bethune

Breast Cancer Res· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Well-differentiated invasive breast cancers with equivocal HER2 immunohistochemistry: what is the yield of routine reflex in-situ hybridization testing?
Gillian C Bethune, Alexandra S L Pettit, Daniel Veldhuijzen van Zanten, Penelope J Barnes

Histopathology· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the 2013 American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 (HER2) testing of invasive breast carcinoma: a focus on tumours assessed as 'equivocal' for HER2 gene amplification by fluorescence in-situ hybridization.
Gillian C Bethune, Daniel Veldhuijzen van Zanten, Rebecca F MacIntosh, Daniel Rayson, Tallal Younis

Histopathology· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detecting intratumoral heterogeneity in routine breast-HER2 testing: low yield of testing multiple blocks.
Gillian C Bethune, J Brendan Mullen, Martin C Chang

Ann Diagn Pathol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2 testing of multifocal invasive breast carcinoma: how many blocks are enough?
Gillian C Bethune, J Brendan Mullen, Martin C Chang

Am J Clin Pathol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and pathologic factors of prognostic significance in penile squamous cell carcinoma in a North American population.
Gillian Bethune, Jeffrey Campbell, Adam Rocker, David Bell, Ricardo Rendon

Urology· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel inflammatory reaction in a tattoo: challenge.
Gillian C Bethune, Rob A Miller, Scott J Murray, Noreen M Walsh

Am J Dermatopathol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidermal growth factor receptor (EGFR) in lung cancer: an overview and update.
Gillian Bethune, Drew Bethune, Neale Ridgway, Zhaolin Xu

J Thorac Dis· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis